Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Helius Medical Technologies Inc (HSDT)

Helius Medical Technologies Inc (HSDT)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 6,075
  • Shares Outstanding, K 3,797
  • Annual Sales, $ 520 K
  • Annual Income, $ -18,130 K
  • 60-Month Beta 0.82
  • Price/Sales 10.76
  • Price/Cash Flow N/A
  • Price/Book 0.50
Trade HSDT with:

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/22
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year -2.58
  • Growth Rate Est. (year over year) +38,820.93%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.3500 +18.53%
on 05/13/22
3.5000 -54.28%
on 04/26/22
-1.4599 (-47.71%)
since 04/13/22
3-Month
1.3500 +18.53%
on 05/13/22
4.7600 -66.38%
on 03/01/22
-2.4625 (-60.61%)
since 02/11/22
52-Week
1.3500 +18.53%
on 05/13/22
17.2600 -90.73%
on 06/25/21
-12.7499 (-88.85%)
since 05/13/21

Most Recent Stories

More News
Helius Medical Technologies, Inc. Reports First Quarter 2022 Financial Results and Provides Update on U.S. Commercial Launch of PoNS®

-- Company to host call at 9:00am today with CEO, CFO, CMO and VP Sales & Marketing -- NEWTOWN, Pa., May 12, 2022 (GLOBE NEWSWIRE) -- Helius...

HSDT : 1.6001 (+8.11%)
Helius Medical Technologies, Inc. to Release First Quarter 2022 Financial Results on May 12, 2022

NEWTOWN, Pa., May 03, 2022 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (NASDAQ: HSDT) (TSX: HSM) (“Helius” or the “Company”), a neurotech...

HSDT : 1.6001 (+8.11%)
HSM.TO : 18.35 (-1.71%)
Helius Medical Technologies, Inc. Fulfills First U.S. Prescriptions for PoNS®

-- First patients have purchased PoNS devices to initiate PoNS Therapy ---- Nineteen PoNS device prescriptions have been written in the U.S. since recent...

HSDT : 1.6001 (+8.11%)
Helius Medical Technologies, Inc. Introduces Device in U.S. To Help Multiple Sclerosis Patients Improve Walking Ability

-- Breakthrough technology for MS patients helps patients with gait deficit -- Portable Neuromodulation Stimulator (PoNS®) is an innovative non-surgical...

HSDT : 1.6001 (+8.11%)
Helius Medical Technologies, Inc. Reports Fourth Quarter and Full Year 2021 Financial Results

NEWTOWN, Pa., March 14, 2022 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (“Helius” or the “Company”), a neurotech company focused...

HSDT : 1.6001 (+8.11%)
Helius Medical Technologies, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

NEWTOWN, Pa., Feb. 17, 2022 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq: HSDT) (“Helius” or the “Company”), a neurotech company focused...

HSDT : 1.6001 (+8.11%)
Helius Medical Technologies, Inc. Provides Corporate Update

-- Fourth Quarter 2021 Revenue Projected to Range from $250,000 to $260,000 -- -- Unaudited Year End Cash Balance of $11 million -- -- Continued...

HSDT : 1.6001 (+8.11%)
Helius Medical Technologies, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

NEWTOWN, Pa., Dec. 20, 2021 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq: HSDT) (“Helius” or the “Company”), a neurotech company focused...

HSDT : 1.6001 (+8.11%)
Helius Medical Technologies, Inc. Partners with the Medical University of South Carolina in Pilot Trial on Stroke

-- PoNS ® to be used in study of cranial-nerve non-invasive neuromodulation and dynamic gait balance in stroke patients -- -- Collaboration will inform...

HSDT : 1.6001 (+8.11%)
Helius Medical Technologies, Inc. Announces Issuance of U.S. Patent for Wireless PoNS®

Patent Readies Company for Next Generation of PoNS Therapy ...

HSDT : 1.6001 (+8.11%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is in highly oversold territory. Beware of a trend reversal.

See More Share

Business Summary

Helius Medical Technologies Inc. is a specialty medical device company. It is focused on the development and regulatory approval of its non-invasive neurostimulation device called PoNS. The Company is nearing clinical trials for balance disorders in TBI patients and for the treatment of MS. Helius Medical...

See More

Key Turning Points

3rd Resistance Point 1.9816
2nd Resistance Point 1.8052
1st Resistance Point 1.7027
Last Price 1.6001
1st Support Level 1.4238
2nd Support Level 1.2474
3rd Support Level 1.1449

See More

52-Week High 17.2600
Fibonacci 61.8% 11.1824
Fibonacci 50% 9.3050
Fibonacci 38.2% 7.4276
Last Price 1.6001
52-Week Low 1.3500

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar